Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

What's new

University of Oxford and Selvita collaborate to advance potential therapeutics for Parkinson's Disease

The University of Oxford and Selvita (WSE: SLV), one of the largest contract research organisations in Europe, are collaborating on drug discovery in the area of Parkinson's disease

“Looking back on my childhood, I can’t ever remember a time when I didn’t feel negative."

A data scientist who was able to return to work after taking medication for severe depression as part of an Oxford research trial has urged others to consider taking part in studies.

Brain and mental health innovation at Oxford

Mental Health and Dementia are a global healthcare crisis, affecting over one billion people worldwide. Of those, over 400 million people are on the Alzheimer's disease continuum, with one person diagnosed every three seconds, and the figure expected to rise as the global population of those over 60 is set to double by 2050.


Follow @OxNeuro